ANDRA AP-FONDEN – Alnylam Pharmaceuticals, Inc. Transaction History
ANDRA AP-FONDEN portfolio value:
$9.72M
portfolio value
ANDRA AP-FONDEN quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +15.44% | 6.5K shares | 3.58M | $200.16 | 48.6K |
| Q2 2022 | share | Increase | +48.24% | 13.7K shares | 1.32M | $145.85 | 42.1K |
| Q4 2021 | share | Increase | +42.71% | 8.5K shares | 1.05M | $171.03 | 28.4K |
| Q3 2021 | share | Increase | +14.37% | 2.5K shares | 807K | $188.81 | 19.9K |
| Q2 2021 | share | Increase | +8.75% | 1.4K shares | 691K | $169.52 | 17.4K |
| Q1 2021 | share | Decrease | -13.51% | -2.5K shares | -145K | $141.19 | 16K |
| Q4 2020 | share | Increase | +30.28% | 4.3K shares | 336K | $129.97 | 18.5K |
| Q3 2020 | share | Decrease | -62.73% | -23.9K shares | -3.57M | $145.6 | 14.2K |
| Q2 2020 | share | Increase | +10.76% | 3.7K shares | 1.89M | $148.11 | 38.1K |
| Q1 2020 | share | Increase | +138.89% | 20K shares | 2.08M | $108.85 | 34.4K |
| Q4 2019 | share | Increase | +414.29% | 11.6K shares | 1.43M | $115.17 | 14.4K |
| Q3 2019 | share | Increase | 0.00% | 2.8K shares | 225K | $80.42 | 2.8K |
| Q2 2019 | share | Decrease | -100.00% | -5.6K shares | -523K | $72.56 | 0 |
| Q1 2019 | share | Increase | 0.00% | 5.6K shares | 523K | $93.45 | 5.6K |
| Q3 2018 | share | Decrease | -100.00% | -12.8K shares | -1.26M | $87.52 | 0 |
| Q2 2018 | share | Decrease | -12.93% | -1.9K shares | -490K | $98.49 | 12.8K |
| Q1 2018 | share | Increase | +673.68% | 12.8K shares | 1.51M | $119.1 | 14.7K |
| Q4 2017 | share | Increase | 0.00% | 1.9K shares | 241K | $127.05 | 1.9K |